跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ICATIBANTO HIKMA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ICATIBANTO HIKMA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
ICATIBANTO HIKMA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2025
Approval ID
2d1e4d2ac241848e
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
2d1e4d2ac241848e
Drug Cima Aemps Name
ICATIBANTO HIKMA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
90237
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2025-03-31
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
30 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2025
Approval ID
2d1e4d2ac241848e
Type
Standard
Back to CIMA-AEMPS Approvals